Cervical cancer in Oujda:
screening, care and HPV prevention.
From Pap smear to full treatment by surgery, radiotherapy and brachytherapy, Clinique Achark in Oujda manages cervical cancer per international guidelines (WHO, ESMO, ESGO).
The 5-step pathway at Clinique Achark in Oujda
- 1. Pap smear + HPV screening
Cervical Pap smear and HPV test from age 25. To be renewed every 3 to 5 years per guidelines.
- 2. Colposcopy + biopsy
In case of an abnormality, colposcopy and targeted biopsy at Clinique Achark in Oujda. On-site pathology.
- 3. Tumour board & staging
Weekly multidisciplinary consultation. 3T pelvic MRI for staging.
- 4. Stage-adapted treatment
Conisation for low-grade lesions; hysterectomy; concurrent chemoradiotherapy + brachytherapy for advanced stages.
- 5. Follow-up & quality of life
Gynaecological surveillance, psychological support and fertility-preservation advice when applicable.
From diagnosis to treatment
Pap smear & high-sensitivity HPV test
Liquid-based cytology + HPV genotyping to identify high-risk strains (16, 18, 31, 33, 45…).
3 Tesla pelvic MRI
Precise staging: tumour size, parametrial involvement, pelvic and para-aortic nodes.
Brachytherapy
Local high-dose irradiation, essential for curative treatment of stages II–III with cervical involvement.
Laparoscopic surgery
Radical hysterectomy by laparoscopy when indicated, to shorten hospital stay.
Frequently asked questions from Oriental-region patients
From age 25 for sexually active women. Renewed every 3 years between 25 and 30, then every 5 years with HPV test up to age 65, per WHO recommendations adapted to Morocco.
Cited medical sources
- WHO — Cervical cancer fact sheet
- ESMO — Gynaecological Cancers Clinical Practice Guidelines
- ESGO — European Society of Gynaecological Oncology guidelines
This page summarises the recommendations of the learned societies listed above, adapted to the clinical practice context at Clinique Achark in Oujda.